US 11447521
Compounds and methods for modulating angiotensinogen expression
granted A61PA61P9/12
Quick answer
US patent 11447521 (Compounds and methods for modulating angiotensinogen expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P9/12